{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-043733","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.556952+00:00","generated_at":"2026-05-21T04:54:16.915508+00:00","sec_items":["5.08","8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Adial Pharmaceuticals sets 2025 Annual Meeting for July 24; proposal deadlines revised","bullets":["Annual meeting scheduled for July 24, 2025; record date June 4, 2025.","Rule 14a-8 stockholder proposal deadline: May 25, 2025.","Director nominations and non-14a-8 proposals due by May 25, 2025.","Universal proxy rule compliance notice also due May 25, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-043733","json":"https://secwatch.observer/filing/0001213900-25-043733.json","markdown":"https://secwatch.observer/filing/0001213900-25-043733.md","text":"https://secwatch.observer/filing/0001213900-25-043733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025043733/0001213900-25-043733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025043733/ea0242287-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:54:16.915508+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}